Related references
Note: Only part of the references are listed.A trivalent vaccine consisting of flagellin A plus B and pilin protects against Pseudomonas aeruginosa infection in a murine burn model
Farhad B. Hashemi et al.
MICROBIAL PATHOGENESIS (2020)
Immunological considerations in the development of Pseudomonas aeruginosa vaccines
Sarah M. Baker et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
Curdlan stimulates tissue mast cells to synthesize pro-inflammatory mediators, generate ROS, and migrate via Dectin-1 receptor
Paulina Zelechowska et al.
CELLULAR IMMUNOLOGY (2020)
Scavenging Bacterial Siderophores with Engineered Lipocalin Proteins as an Alternative Antimicrobial Strategy
Martin Dauner et al.
CHEMBIOCHEM (2020)
Viral Vectors, Animal Models, and Cellular Targets for Gene Therapy of Cystic Fibrosis Lung Disease
Yinghua Tang et al.
HUMAN GENE THERAPY (2020)
Recombinant N-terminal outer membrane porin (OprF) of Pseudomonas aeruginosa is a promising vaccine candidate against both P. aeruginosa and some strains of Acinetobacter baumannii
Mohammed Bahey-El-Din et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2020)
Integrated Genome-Wide Analysis of an Isogenic Pair of Pseudomonas aeruginosa Clinical Isolates with Differential Antimicrobial Resistance to Ceftolozane/Tazobactam, Ceftazidime/Avibactam, and Piperacillin/Tazobactam
Weihua Huang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Neutrophil Adaptations upon Recruitment to the Lung: New Concepts and Implications for Homeostasis and Disease
Vincent D. Giacalone et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Polyester based polymeric nano and microparticles for pharmaceutical purposes: A review on formulation approaches
Fatima Molavi et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Host responses to mucosal biofilms in the lung and gut
Jada C. Domingue et al.
MUCOSAL IMMUNOLOGY (2020)
The Role of Pseudomonas aeruginosa Lipopolysaccharide in Bacterial Pathogenesis and Physiology
Steven M. Huszczynski et al.
PATHOGENS (2020)
A live auxotrophic vaccine confers mucosal immunity and protection against lethal pneumonia caused by Pseudomonas aeruginosa
Maria P. Cabral et al.
PLOS PATHOGENS (2020)
The Effects of Secretory IgA in the Mucosal Immune System
Yue Li et al.
BIOMED RESEARCH INTERNATIONAL (2020)
TLR5 participates in the TLR4 receptor complex and promotes MyD88-dependent signaling in environmental lung injury
Salik Hussain et al.
ELIFE (2020)
Mice Lacking γδ T Cells Exhibit Impaired Clearance of Pseudomonas aeruginosa Lung Infection and Excessive Production of Inflammatory Cytokines
Toka Omar et al.
INFECTION AND IMMUNITY (2020)
TAS2R38 is a novel modifier gene in patients with cystic fibrosis
Alice Castaldo et al.
SCIENTIFIC REPORTS (2020)
Progress in Model Systems of Cystic Fibrosis Mucosal Inflammation to Understand Aberrant Neutrophil Activity
Daniel R. Laucirica et al.
FRONTIERS IN IMMUNOLOGY (2020)
Assessing the Feasibility of Typhoid Elimination
Jeffrey D. Stanaway et al.
CLINICAL INFECTIOUS DISEASES (2020)
SARS-CoV-2 will constantly sweep its tracks: a vaccine containing CpG motifs in 'lasso' for the multi-faced virus
V. V. Oberemok et al.
INFLAMMATION RESEARCH (2020)
Protective Efficacy of the OprF/OprI/PcrV Recombinant Chimeric Protein Against Pseudomonas aeruginosa in the Burned BALB/c Mouse Model
Mohammad Hadi Fakoor et al.
INFECTION AND DRUG RESISTANCE (2020)
Immunopotentiation of the engineered low-molecular-weight pilin targeting Pseudomonas aeruginosa: A combination of immunoinformatics investigation and active immunization
Yasaman Ahmadbeigi et al.
MOLECULAR IMMUNOLOGY (2020)
Oligomerization of IC43 resulted in improved immunogenicity and protective efficacy against Pseudomonas aeruginosa lung infection
Haiming Jing et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
In-Silico Analysis and Protective Efficacy of the PcrV Recombinant Vaccine against Pseudomonas Aeruginosa in the Burned and PA-Infected BALB/c Mouse Model
Mohammad Hadi Fakoor et al.
IRANIAN JOURNAL OF IMMUNOLOGY (2020)
Efficacy, immunogenicity, and safety of IC43 recombinant Pseudomonas aeruginosa vaccine in mechanically ventilated intensive care patients-a randomized clinical trial
Christopher Adlbrecht et al.
CRITICAL CARE (2020)
Updates on the pathogenicity status of Pseudomonas aeruginosa
Mohd W. Azam et al.
DRUG DISCOVERY TODAY (2019)
Updates on T helper type 17 immunity in respiratory disease
Naoki Iwanaga et al.
IMMUNOLOGY (2019)
Secretory IgA-mediated immune response in saliva and early detection of Pseudomonas aeruginosa in the lower airways of pediatric cystic fibrosis patients
Renan Marrichi Mauch et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2019)
Mechanistic research holds promise for bacterial vaccines and phage therapies for Pseudomonas aeruginosa
Austin Hoggarth et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface
Sankalp Malhotra et al.
CLINICAL MICROBIOLOGY REVIEWS (2019)
Selection of adjuvants for vaccines targeting specific pathogens
Indranil Sarkar et al.
EXPERT REVIEW OF VACCINES (2019)
Hydrogen peroxide-inactivated bacteria induces potent humoral and cellular immune responses and releases nucleic acids
Yingzi Fan et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Cathelicidin is a fire alarm, generating protective NLRP3-dependent airway epithelial cell inflammatory responses during infection with Pseudomonas aeruginosa
Brian J. McHugh et al.
PLOS PATHOGENS (2019)
A Live Salmonella Vaccine Delivering PcrV through the Type III Secretion System Protects against Pseudomonas aeruginosa
Julia Aguilera-Herce et al.
MSPHERE (2019)
Mucosal vaccines and technology
A. Miquel-Clopes et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2019)
Immunization with the ferric iron-binding periplasmic protein HitA provides protection against Pseudomonas aeruginosa in the murine infection model
Mona A. Elhosary et al.
MICROBIAL PATHOGENESIS (2019)
Exotoxin A-PLGA nanoconjugate vaccine against Pseudomonas aeruginosa infection: protectivity in murine model
Leila Safari Zanjani et al.
WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY (2019)
Killing from the inside: Intracellular role of T3SS in the fate of Pseudomonas aeruginosa within macrophages revealed by mgtC and oprF mutants
Preeti Garai et al.
PLOS PATHOGENS (2019)
Relationship Between Quorum Sensing and Secretion Systems
Rocio Trastoy Pena et al.
FRONTIERS IN MICROBIOLOGY (2019)
Can Biofilm Be Reversed Through Quorum Sensing in Pseudomonas aeruginosa?
Shaomin Yan et al.
FRONTIERS IN MICROBIOLOGY (2019)
Rational Design of a Chimeric Derivative of PcrV as a Subunit Vaccine Against Pseudomonas aeruginosa
Chuang Wan et al.
FRONTIERS IN IMMUNOLOGY (2019)
Regulation of Pseudomonas aeruginosa-Mediated Neutrophil Extracellular Traps
Sladjana Skopelja-Gardner et al.
FRONTIERS IN IMMUNOLOGY (2019)
Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections
Juan P. Horcajada et al.
CLINICAL MICROBIOLOGY REVIEWS (2019)
Intranasal Peptide-Based FpvA-KLH Conjugate Vaccine Protects Mice From Pseudomonas aeruginosa Acute Murine Pneumonia
Emel Sen-Kilic et al.
FRONTIERS IN IMMUNOLOGY (2019)
Gamma Interferon and Interleukin-17A Differentially Influence the Response of Human Macrophages and Neutrophils to Pseudomonas aeruginosa Infection
Sirina Muntaka et al.
INFECTION AND IMMUNITY (2019)
The Pseudomonas aeruginosa HSP70-like protein DnaK induces IL-1β expression via TLR4-dependent activation of the NF-κB and JNK signaling pathways
Jung-Hoon Lee et al.
COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES (2019)
Intradermal vaccination with a Pseudomonas aeruginosa vaccine adjuvanted with a mutant bacterial ADP-ribosylating enterotoxin protects against acute pneumonia
Sarah M. Baker et al.
VACCINE (2019)
Persistence and Microevolution of Pseudomonas aeruginosa in the Cystic Fibrosis Lung: A Single-Patient Longitudinal Genomic Study
Irene Bianconi et al.
FRONTIERS IN MICROBIOLOGY (2019)
Animal Models in the Pathophysiology of Cystic Fibrosis
Anna Semaniakou et al.
FRONTIERS IN PHARMACOLOGY (2019)
Genome-Based Approach Delivers Vaccine Candidates Against Pseudomonas aeruginosa
Irene Bianconi et al.
FRONTIERS IN IMMUNOLOGY (2019)
Tasked with a Challenging Objective: Why Do Neutrophils Fail to Battle Pseudomonas aeruginosa Biofilms
Jennifer Geddes-McAlister et al.
PATHOGENS (2019)
Quorum Machinery: Effect of the las System in rhl Regulation of P. aeruginosa
Cicik Alfiniyah et al.
PROCEEDINGS OF THE 8TH SEAMS-UGM INTERNATIONAL CONFERENCE ON MATHEMATICS AND ITS APPLICATIONS 2019: DEEPENING MATHEMATICAL CONCEPTS FOR WIDER APPLICATION THROUGH MULTIDISCIPLINARY RESEARCH AND INDUSTRIES COLLABORATIONS (2019)
Membrane vesicles from Pseudomonas aeruginosa activate the noncanonical inflammasome through caspase-5 in human monocytes
Natalie J. Bitto et al.
IMMUNOLOGY AND CELL BIOLOGY (2018)
NOD-like receptor(s) and host immune responses with Pseudomonas aeruginosa infection
Alaa Alhazmi
INFLAMMATION RESEARCH (2018)
IgG avidity to Pseudomonas aeruginosa over the course of chronic lung biofilm infection in cystic fibrosis
Renan Marrichi Mauch et al.
JOURNAL OF CYSTIC FIBROSIS (2018)
Mechanisms of humoral immune response against Pseudomonas aeruginosa biofilm infection in cystic fibrosis
Renan Marrichi Mauch et al.
JOURNAL OF CYSTIC FIBROSIS (2018)
Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa
Ramadan Hassan et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2018)
Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
Evelina Tacconelli et al.
LANCET INFECTIOUS DISEASES (2018)
Regulator of calcineurin 1 differentially regulates TLR-dependent MyD88 and TRIF signaling pathways
Zheng Pang et al.
PLOS ONE (2018)
Immune efficacy of DNA vaccines based on oprL and oprF genes of Pseudomonas aeruginosa in chickens
Q. Gong et al.
POULTRY SCIENCE (2018)
Correlates of adjuvanticity: A review on adjuvants in licensed vaccines
Giuseppe Del Giudice et al.
SEMINARS IN IMMUNOLOGY (2018)
Killed but metabolically active Pseudomonas aeruginosa-based vaccine induces protective humoral- and cell-mediated immunity against Pseudomonas aeruginosa pulmonary infections
Elodie Meynet et al.
VACCINE (2018)
Immunology and efficacy of MF59-adjuvanted vaccines
Eun-Ju Ko et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent F. tularensis subsp tularensis
Qingmei Jia et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2018)
Construction of a Protective Vaccine Against Lipopolysaccharide-Heterologous Pseudomonas aeruginosa Strains Based on Expression Profiling of Outer Membrane Proteins During Infection
Chang Liu et al.
FRONTIERS IN IMMUNOLOGY (2018)
The Mucosal Vaccine Adjuvant LT(R192G/L211A) or dmLT
John D. Clements et al.
MSPHERE (2018)
The protective effects of nasal PcrV-CpG oligonucleotide vaccination against Pseudomonas aeruginosa pneumonia
Yoshifumi Naito et al.
MICROBIOLOGY AND IMMUNOLOGY (2018)
PLGA-encapsulation of the Pseudomonas aeruginosa PopB vaccine antigen, improves Th17 responses and confers protection against experimental acute pneumonia
Matthew M. Schaefers et al.
VACCINE (2018)
Interleukin-13 Stimulation Reveals the Cellular and Functional Plasticity of the Airway Epithelium
Max A. Seibold
ANNALS OF THE AMERICAN THORACIC SOCIETY (2018)
Synthesis and immunological evaluation of a nanovaccine based on PLGA nanoparticles and alginate antigen against infections caused by Pseudomonas aeruginosa
Zahra Alikhani et al.
BIOMEDICAL PHYSICS & ENGINEERING EXPRESS (2018)
Understanding modern-day vaccines: what you need to know
Volker Vetter et al.
ANNALS OF MEDICINE (2018)
Airway disease phenotypes in animal models of cystic fibrosis
Alexandra McCarron et al.
RESPIRATORY RESEARCH (2018)
Inflammation: A Double-Edged Sword in the Response to Pseudomonas aeruginosa Infection
Christina K. Lin et al.
JOURNAL OF INNATE IMMUNITY (2017)
Immunogenicity of a fusion protein containing PilQ and disulphide turn region of PilA from Pseudomonas aeruginosa in mice
M. Gholami et al.
LETTERS IN APPLIED MICROBIOLOGY (2017)
Efficacy comparison of adjuvants in PcrV vaccine against Pseudomonas aeruginosa pneumonia
Saeko Hamaoka et al.
MICROBIOLOGY AND IMMUNOLOGY (2017)
Post-exposure immunization by capsid-modified AdC7 vector expressing Pseudomonas aeruginosa OprF clears P. aeruginosa respiratory infection
Rika Gomi et al.
VACCINE (2017)
Signaling Mediated by Toll-Like Receptor 5 Sensing of Pseudomonas aeruginosa Flagellin Influences IL-1β and IL-18 Production by Primary Fibroblasts Derived from the Human Cornea
Maria del Mar Cendra et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2017)
The anti-microbial peptide TP359 attenuates inflammation in human lung cells infected with Pseudomonas aeruginosa via TLR5 and MAPK pathways
Ejovwoke F. Dosunmu et al.
PLOS ONE (2017)
Bioengineering a bacterial pathogen to assemble its own particulate vaccine capable of inducing cellular immunity
Jason W. Lee et al.
SCIENTIFIC REPORTS (2017)
Protective Efficacy of the Trivalent Pseudomonas aeruginosa Vaccine Candidate PcrV-OprI-Hcp1 in Murine Pneumonia and Burn Models
Feng Yang et al.
SCIENTIFIC REPORTS (2017)
SLC6A14 Is a Genetic Modifier of Cystic Fibrosis That Regulates Pseudomonas aeruginosa Attachment to Human Bronchial Epithelial Cells
Michelle Di Paola et al.
MBIO (2017)
Vaccination with a recombinant OprL fragment induces a Th17 response and confers serotype-independent protection against Pseudomonas aeruginosa infection in mice
Chen Gao et al.
CLINICAL IMMUNOLOGY (2017)
Increased Immunogenicity and Protective Efficacy of a P. aeruginosa Vaccine in Mice Using an Alum and De-O-Acylated Lipooligosaccharide Adjuvant System
Ji In Ryu et al.
JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY (2017)
Structure, function and regulation of Pseudomonas aeruginosa porins
Sylvie Chevalier et al.
FEMS MICROBIOLOGY REVIEWS (2017)
Pseudomonas aeruginosa Biofilm, a Programmed Bacterial Life for Fitness
Keehoon Lee et al.
JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY (2017)
Preparation of Pseudomonas aeruginosa alginate-flagellin immunoconjugate
Sobhan Faezi et al.
BIOLOGICALS (2017)
Construction, expression, purification and characterization of secretin domain of PilQ and triple PilA-related disulfide loop peptides fusion protein from Pseudomonas aeruginosa
Sobhan Faezi et al.
IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES (2017)
Interactions between Neutrophils and Pseudomonas aeruginosa in Cystic Fibrosis
Balazs Rada
PATHOGENS (2017)
A randomized placebo-controlled phase II study of a Pseudomonas vaccine in ventilated ICU patients
Jordi Rello et al.
CRITICAL CARE (2017)
Airway surface liquid homeostasis in cystic fibrosis: pathophysiology and therapeutic targets
Iram J. Haq et al.
THORAX (2016)
Protective effect of pilin protein with alum plus naloxone adjuvant against acute pulmonary Pseudomonas aeruginosa infection
Abbas Zare Banadkoki et al.
BIOLOGICALS (2016)
Immunogenicity of Pseudomonas aeruginosa recombinant b-type fagellin as a vaccine candidate: Protective efficacy in a murine burn wound sepsis model
Bahador Behrouz et al.
BURNS (2016)
Dysregulated Chemokine Signaling in Cystic Fibrosis Lung Disease: A Potential Therapeutic Target
Xiaoqing Guan et al.
CURRENT DRUG TARGETS (2016)
Flagellin and pilin immunization against multi-drug resistant Pseudomonas aeruginosa protects mice in the burn wound sepsis model
Fatemeh Korpi et al.
IMMUNOLOGY LETTERS (2016)
Toll-Like Receptor 4 Agonistic Antibody Promotes Host Defense against Chronic Pseudomonas aeruginosa Lung Infection in Mice
Shigeki Nakamura et al.
INFECTION AND IMMUNITY (2016)
Interleukin-17 Is Required for Control of Chronic Lung Infection Caused by Pseudomonas aeruginosa
Hannah K. Bayes et al.
INFECTION AND IMMUNITY (2016)
Heterologous Pseudomonas aeruginosa O-antigen delivery using a Salmonella enterica serovar Typhimurium wecA mutant strain
Dacie R. Bridge et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2016)
Clinical Isolates of Pseudomonas aeruginosa from Chronically Infected Cystic Fibrosis Patients Fail To Activate the Inflammasome during Both Stable Infection and Pulmonary Exacerbation
Kelsey E. Huus et al.
JOURNAL OF IMMUNOLOGY (2016)
CXCR1 Regulates Pulmonary Anti-Pseudomonas Host Defense
M. Carevic et al.
JOURNAL OF INNATE IMMUNITY (2016)
Current Concepts and Controversies on Innate Immunity of Cystic Fibrosis Lung Disease
Anjali Ralhan et al.
JOURNAL OF INNATE IMMUNITY (2016)
Immunogenicity and protective efficacy of Pseudomonas aeruginosa type a and b flagellin vaccines in a burned mouse model
Parisa Laghaei et al.
MOLECULAR IMMUNOLOGY (2016)
Pseudomonas aeruginosa Evolutionary Adaptation and Diversification in Cystic Fibrosis Chronic Lung Infections
Craig Winstanley et al.
TRENDS IN MICROBIOLOGY (2016)
Targeting the Type Three Secretion System in Pseudomonas aeruginosa
Ahalieyah Anantharajah et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Induction of humoral immune response against Pseudomonas aeruginosa flagellin(1-161) using gold nanoparticles as an adjuvant
Farida Dakterzada et al.
VACCINE (2016)
A DNA vaccine encoding VP22 of herpes simplex virus type I (HSV-1) and OprF confers enhanced protection from Pseudomonas aeruginosa in mice
Xian Yu et al.
VACCINE (2016)
Vaccine adjuvants: Why and how
Dennis Christensen
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
Cellular Effects of Pyocyanin, a Secreted Virulence Factor of Pseudomonas aeruginosa
Susan Hall et al.
TOXINS (2016)
A De-O-acylated Lipooligosaccharide-Based Adjuvant System Promotes Antibody and Th1-Type Immune Responses to H1N1 Pandemic Influenza Vaccine in Mice
Ji In Ryu et al.
BIOMED RESEARCH INTERNATIONAL (2016)
IL17-Producing γδ T Cells May Enhance Humoral Immunity during Pulmonary Pseudomonas aeruginosa Infection in Mice
Tingting Pan et al.
Frontiers in Cellular and Infection Microbiology (2016)
Adjuvants: Classification, Modus Operandi, and Licensing
Juliana de Souza Apostolico et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Tracking the immunopathological response to Pseudomonas aeruginosa during respiratory infections
Cristina Cigana et al.
SCIENTIFIC REPORTS (2016)
Comparative genomics and biological characterization of sequential Pseudomonas aeruginosa isolates from persistent airways infection
Irene Bianconi et al.
BMC GENOMICS (2015)
Immunization with 3-oxododecanoyl-L-homoserine lactone-r-PcrV conjugate enhances survival of mice against lethal burn infections caused by Pseudomonas aeruginosa
Isar Dejban Golpasha et al.
Bosnian Journal of Basic Medical Sciences (2015)
Protective efficacy of recombinant exotoxin A - flagellin fusion protein against Pseudomonas aeruginosa infection
Safar Farajnia et al.
CANADIAN JOURNAL OF MICROBIOLOGY (2015)
Identification of OprF as a Complement Component C3 Binding Acceptor Molecule on the Surface of Pseudomonas aeruginosa
Meenu Mishra et al.
INFECTION AND IMMUNITY (2015)
Salmonella Typhimurium strain expressing OprF-OprI protects mice against fatal infection by Pseudomonas aeruginosa
Mingliang Zhang et al.
MICROBIOLOGY AND IMMUNOLOGY (2015)
Phenotypic characterization of an international Pseudomonas aeruginosa reference panel: strains of cystic fibrosis (CF) origin show less in vivo virulence than non-CF strains
Louise Cullen et al.
MICROBIOLOGY-SGM (2015)
Vaccines, adjuvants and autoimmunity
Luisa Eca Guimaraes et al.
PHARMACOLOGICAL RESEARCH (2015)
Over-Expression and Immunogenicity of Outer Membrane Protein L (OprL) of Pseudomonas aeruginosa
S. A. Ingle et al.
Proceedings of the National Academy of Sciences, India. Section B (2015)
Advances in aluminum hydroxide-based adjuvant research and its mechanism
Peng He et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
Pseudomonas aeruginosa PAO-1 Lipopolysaccharide-Diphtheria Toxoid Conjugate Vaccine: Preparation, Characterization and Immunogenicity
Faezeh Najafzadeh et al.
JUNDISHAPUR JOURNAL OF MICROBIOLOGY (2015)
Exome Sequencing of Phenotypic Extremes Identifies CAV2 and TMC6 as Interacting Modifiers of Chronic Pseudomonas aeruginosa Infection in Cystic Fibrosis
Mary J. Emond et al.
PLOS GENETICS (2015)
Pseudomonas Exotoxin A: optimized by evolution for effective killing
Marta Michalska et al.
FRONTIERS IN MICROBIOLOGY (2015)
Genetic engineering of Francisella tularensis LVS for use as a novel live vaccine platform against Pseudomonas aeruginosa infections
Cory M. Robinson et al.
BIOENGINEERED (2015)
Immunological evaluation of an alginate-based conjugate as a vaccine candidate against Pseudomonas aeruginosa
Ali Farjah et al.
APMIS (2015)
Mannose-modified chitosan microspheres enhance OprF-OprI-mediated protection of mice against Pseudomonas aeruginosa infection via induction of mucosal immunity
Ziyin Cui et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2015)
Expression of the lipopolysaccharide biosynthesis gene lpxD affects biofilm formation of Pseudomonas aeruginosa
Sahar A. Alshalchi et al.
ARCHIVES OF MICROBIOLOGY (2015)
Pseudomonas chemotaxis
Inmaculada Sampedro et al.
FEMS MICROBIOLOGY REVIEWS (2015)
Redundant and Cooperative Interactions between TLR5 and NLRC4 in Protective Lung Mucosal Immunity against Pseudomonas aeruginosa
Leslie Tolle et al.
JOURNAL OF INNATE IMMUNITY (2015)
Granulocyte-Macrophage Colony Stimulatory Factor Enhances the Pro-Inflammatory Response of Interferon-γ-Treated Macrophages to Pseudomonas aeruginosa Infection
Sonali Singh et al.
PLOS ONE (2015)
Vaccination against respiratory Pseudomonas aeruginosa infection
Keith Grimwood et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)
The hierarchy quorum sensing network in Pseudomonas aeruginosa
Jasmine Lee et al.
PROTEIN & CELL (2015)
Bacterial Adaptation during Chronic Respiratory Infections
Louise Cullen et al.
PATHOGENS (2015)
Mechanisms of phagocytosis and host clearance of Pseudomonas aeruginosa
Rustin R. Lovewell et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2014)
Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection
Sobhan Faezi et al.
APMIS (2014)
Polymorphonuclear Leukocytes Restrict Growth of Pseudomonas aeruginosa in the Lungs of Cystic Fibrosis Patients
Kasper N. Kragh et al.
INFECTION AND IMMUNITY (2014)
Conjugation of alginate to a synthetic peptide containing T- and B-cell epitopes as an induction for protective immunity against Pseudomonas aeruginosa
Ali Farjah et al.
JOURNAL OF BIOTECHNOLOGY (2014)
Toll-Like Receptor 9 Deficiency Protects Mice against Pseudomonas aeruginosa Lung Infection
Fatima BenMohamed et al.
PLOS ONE (2014)
Protective Effect of DNA Vaccine Encoding Pseudomonas Exotoxin A and PcrV against Acute Pulmonary P. aeruginosa Infection
Mingzi Jiang et al.
PLOS ONE (2014)
The B Lymphocyte Differentiation Factor (BAFF) Is Expressed in the Airways of Children with CF and in Lungs of Mice Infected with Pseudomonas aeruginosa
Daniel R. Neill et al.
PLOS ONE (2014)
Within-Host Evolution of Pseudomonas aeruginosa Reveals Adaptation toward Iron Acquisition from Hemoglobin
Rasmus Lykke Marvig et al.
MBIO (2014)
A randomized, placebo-controlled phase I study assessing the safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein OprE/I vaccine (IC43) in healthy volunteers
Kerstin Westritschnig et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
Th17 Cells in Immunity and Autoimmunity
Simone Kennedy Bedoya et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2013)
Bacterial sinusitis can be a focus for initial lung colonisation and chronic lung infection in patients with cystic fibrosis
Kasper Aanaes
JOURNAL OF CYSTIC FIBROSIS (2013)
Key roles of adjuvants in modern vaccines
Steven G. Reed et al.
NATURE MEDICINE (2013)
Mucosal and systemic antibody responses to potential Pseudomonas aeruginosa vaccine protein antigens in young children with cystic fibrosis following colonization and infection
Ryka Moore et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Pseudomonas aeruginosa Recombinant Flagellin Induced Poly-Isotypic Humoral Immune Responses in the Balb/C Mice
Arezoo Shajiei et al.
JUNDISHAPUR JOURNAL OF MICROBIOLOGY (2013)
Pseudomonas aeruginosa adapts its iron uptake strategies in function of the type of infections
Pierre Cornelis et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2013)
Protective Properties of Nontoxic Recombinant Exotoxin A (Domain I-II) Against Pseudomonas aeruginosa Infection
Asghar Tanomand et al.
IRANIAN JOURNAL OF BIOTECHNOLOGY (2013)
Pseudomonas aeruginosa: new insights into pathogenesis and host defenses
Shaan L. Gellatly et al.
PATHOGENS AND DISEASE (2013)
Th17-stimulating Protein Vaccines Confer Protection against Pseudomonas aeruginosa Pneumonia
Weihui Wu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Pseudomonas aeruginosa Twitching Motility: Type IV Pili in Action
Lori L. Burrows
ANNUAL REVIEW OF MICROBIOLOGY, VOL 66 (2012)
40 years on: have we finally got a vaccine for Pseudomonas aeruginosa?
Stefan Worgall
FUTURE MICROBIOLOGY (2012)
Toll-Like Receptor 2 Deficiency Increases Resistance to Pseudomonas aeruginosa Pneumonia in the Setting of Sepsis-Induced Immune Dysfunction
Frederic Pene et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Toll-like receptors in the host defense against Pseudomonas aeruginosa respiratory infection and cystic fibrosis
Shayla M. McIsaac et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective
Anders Folkesson et al.
NATURE REVIEWS MICROBIOLOGY (2012)
Pseudomonas biofilm matrix composition and niche biology
Ethan E. Mann et al.
FEMS MICROBIOLOGY REVIEWS (2012)
Contribution of an arsenal of virulence factors to pathogenesis of Pseudomonas aeruginosa infections
Tanya Strateva et al.
ANNALS OF MICROBIOLOGY (2011)
Polymorphism of mucA and fpvA genes in Pseudomonas aeruginosa isolates from cystic fibrosis patients: co-existence of genetically different variants
Maria Jose Pozuelo et al.
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (2011)
Cystic fibrosis modifier genes related to Pseudomonas aeruginosa infection
J. E. Park et al.
GENES AND IMMUNITY (2011)
Recent developments for Pseudomonas vaccines
Anurag Sharma et al.
HUMAN VACCINES (2011)
Th17 Cells Mediate Clade-Specific, Serotype-Independent Mucosal Immunity
Kong Chen et al.
IMMUNITY (2011)
Naloxone and alum synergistically augment adjuvant activities of each other in a mouse vaccine model of Salmonella typhimurium infection
Nima Hosseini Jazani et al.
IMMUNOBIOLOGY (2011)
Mucosal Vaccination with a Multivalent, Live-Attenuated Vaccine Induces Multifactorial Immunity against Pseudomonas aeruginosa Acute Lung Infection
Akinobu Kamei et al.
INFECTION AND IMMUNITY (2011)
Efficacy of a Conjugate Vaccine Containing Polymannuronic Acid and Flagellin against Experimental Pseudomonas aeruginosa Lung Infection in Mice
Victoria L. Campodonico et al.
INFECTION AND IMMUNITY (2011)
Airway Epithelial MyD88 Restores Control of Pseudomonas aeruginosa Murine Infection via an IL-1-Dependent Pathway
Lilia A. Mijares et al.
JOURNAL OF IMMUNOLOGY (2011)
Innate immune responses to Pseudomonas aeruginosa infection
Elise G. Lavoie et al.
MICROBES AND INFECTION (2011)
Protective anti-Pseudomonas aeruginosa humoral and cellular mucosal immunity by AdC7-mediated expression of the P. aeruginosa protein OprF
Anja Krause et al.
VACCINE (2011)
Azithromycin Maintains Airway Epithelial Integrity during Pseudomonas aeruginosa Infection
Skarphedinn Halldorsson et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2010)
Synthetic Peptide Vaccine Development: Designing Dual Epitopes into a Single Pilin Peptide Immunogen Generates Antibody Cross-reactivity between Two Strains of Pseudomonas aeruginosa
Clifton Hackbarth et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2010)
TLR5 or NLRC4 is necessary and sufficient for promotion of humoral immunity by flagellin
Matam Vijay-Kumar et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Evaluation of Flagella and Flagellin of Pseudomonas aeruginosa as Vaccines
Victoria L. Campodonico et al.
INFECTION AND IMMUNITY (2010)
Pseudomonas aeruginosa Evasion of Phagocytosis Is Mediated by Loss of Swimming Motility and Is Independent of Flagellum Expression
Eyal Amiel et al.
INFECTION AND IMMUNITY (2010)
Prevention of Pseudomonas aeruginosa infection in cystic fibrosis patients
Gerd Doering
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2010)
Protein secretion systems in Pseudomonas aeruginosa: A wealth of pathogenic weapons
Sophie Bleves et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2010)
Systemic, nasal and oral live vaccines against Pseudomonas aeruginosa: A clinical trial of immunogenicity in lower airways of human volunteers
Dirk Bumann et al.
VACCINE (2010)
Depletion of phagocytes in the reticuloendothelial system causes increased inflammation and mortality in rabbits with Pseudomonas aeruginosa pneumonia
Kiyoyasu Kurahashi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2009)
Role of Toll-like receptor 5 in the innate immune response to acute P. aeruginosa pneumonia
Amy E. Morris et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2009)
Active immunization using exotoxin A confers protection against Pseudomonas aeruginosa infection in a mouse burn model
Ali Manafi et al.
BMC MICROBIOLOGY (2009)
Advantages of a Synthetic Peptide Immunogen Over a Protein Immunogen in the Development of an Anti-Pilus Vaccine for Pseudomonas aeruginosa
Daniel J. Kao et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2009)
β-glucan recognition by the innate immune system
Helen S. Goodridge et al.
IMMUNOLOGICAL REVIEWS (2009)
A Fusion Protein Vaccine Containing OprF Epitope 8, OprI, and Type A and B Flagellins Promotes Enhanced Clearance of Nonmucoid Pseudomonas aeruginosa
Eric T. Weimer et al.
INFECTION AND IMMUNITY (2009)
Lipopolysaccharide biosynthesis in Pseudomonas aeruginosa
Jerry D. King et al.
INNATE IMMUNITY (2009)
Proteomic Identification of OprL as a Seromarker for Initial Diagnosis of Pseudomonas aeruginosa Infection of Patients with Cystic Fibrosis
Aparna R. Rao et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Protective effects of affinity-purified antibody and truncated vaccines against Pseudomonas aeruginosa V-antigen in neutropenic mice
Kiyoshi Moriyama et al.
MICROBIOLOGY AND IMMUNOLOGY (2009)
Immune response mechanisms against Pseudomonas aeruginosa associated with mucosal immunization with protein antigens in a rat model of acute lung infection
Linda D. Thomas et al.
VACCINE (2009)
Immune responses in the airways by nasal vaccination with systemic boosting against Pseudomonas aeruginosa in chronic lung diseased
Stephan Sorichter et al.
VACCINE (2009)
Immunization of young African green monkeys with OprF epitope 8-OprI-type A- and B-flagellin fusion proteins promotes the production of protective antibodies against nonmucoid Pseudomonas aeruginosa
Eric T. Weimer et al.
VACCINE (2009)
Immunization with a Pseudomonas aeruginosa 1244 pilin provides O-antigen-specific protection
Joseph Horzempa et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
IL-17 is a critical component of vaccine-induced protection against lung infection by lipopolysaccharide-heterologous strains of Pseudomonas aeruginosa
Gregory P. Priebe et al.
JOURNAL OF IMMUNOLOGY (2008)
Protective immunity to Pseudomonas aeruginosa induced with a capsid-modified adenovirus expressing P. aeruginosa OprF
Stefan Worgall et al.
JOURNAL OF VIROLOGY (2007)
Animal protection and structural studies of a consensus sequence vaccine targeting the receptor binding domain of the type IV pilus of Pseudomonas aeruginosa
Daniel J. Kao et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
LPS-based conjugate vaccines composed of O-polysaccharide from Pseudomonas aeruginosa IATS 6 and 11 bound to a carrier protein
Munir Al-Zeer et al.
WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY (2007)
Assessment of pulmonary antibodies with induced sputum and bronchoalveolar lavage induced by nasal vaccination against Pseudomonas aeruginosa:: A clinical phase I/II study
Ulrich Baumann et al.
RESPIRATORY RESEARCH (2007)
Blocking of the TLR5 activation domain hampers protective potential of flagellin DNA vaccine
Sukumar Saha et al.
JOURNAL OF IMMUNOLOGY (2007)
A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients
Gerd Doering et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Intranasal immunization with heterologously expressed polysaccharide protects against multiple Pseudomonas aeruginosa infections
Antonio DiGiandomenico et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Redundant Toll-like receptor signaling in the pulmonary host response to Pseudomonas aeruginosa
Shawn J. Skerrett et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2007)
CXCL1/KC and CXCL5/LIX are selectively produced by corneal fibroblasts and mediate neutrophil infiltration to the corneal stroma in LPS keratitis
Michelle Lin et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Immunization with 3-oxododecanoyl-L-homoserine lactone-protein conjugate protects mice from lethal Pseudomonas aeruginosa lung infection
Shinichi Miyairi et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2006)
Synthesis and characterization of Pseudomonas aeruginosa alginate-tetanus toxoid conjugate
Nasim Kashef et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2006)
Multivalent DNA vaccine protects mice against pulmonary infection caused by Pseudomonas aeruginosa
Sukumar Saha et al.
VACCINE (2006)
Antibody responses induced by long-term vaccination with an octovalent conjugate Pseudomonas aeruginosa vaccine in children with cystic fibrosis
Adrian W. Zuercher et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2006)
Rhamnolipids are virulence factors that promote early infiltration of primary human airway epithelia by Pseudomonas aeruginosa
L Zulianello et al.
INFECTION AND IMMUNITY (2006)
Intratracheal immunization with pili protein protects against mortality associated with Pseudomonas aeruginosa pneumonia in mice
Minoru Ohama et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2006)
Antibody interference with N-acyl homoserine lactone-mediated bacterial quorum sensing
GF Kaufmann et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2006)
A live-attenuated Pseudomonas aeruginosa vaccine elicits outer membrane protein-specific active and passive protection against corneal infection
TS Zaidi et al.
INFECTION AND IMMUNITY (2006)
Safety and immunogenicity of an oral inactivated whole-cell Pseudomonas aeruginosa vaccine administered to healthy human subjects
AW Cripps et al.
INFECTION AND IMMUNITY (2006)
Cellular immunity in healthy volunteers treated with an octavalent conjugate Pseudomonas aeruginosa vaccine
AW Zuercher et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2006)
Intranasal immunization strategy to impede pilin-mediated binding of Pseudomonas aeruginosa to airway epithelial cells
JC Hsieh et al.
INFECTION AND IMMUNITY (2005)
TLRs 2 and 4 are not involved in hypersusceptibility to acute Pseudomonas aeruginosa lung infections
R Ramphal et al.
JOURNAL OF IMMUNOLOGY (2005)
Significant differences in type IV pilin allele distribution among Pseudomonas aeruginosa isolates from cystic fibrosis (CF) versus non-CIF patients
JV Kus et al.
MICROBIOLOGY-SGM (2004)
Recombinant OprF-OprI as a vaccine against Pseudomonas aeruginosa infections
U Baumann et al.
VACCINE (2004)
Crystallographic analysis of the Pseudomonas aeruginosa strain K122-4 monomeric pilin reveals a conserved receptor-binding architecture
GF Audette et al.
BIOCHEMISTRY (2004)
Oral vaccination of BALB/c mice with Salmonella enterica serovar typhimurium expressing Pseudomonas aeruginosa O antigen promotes increased survival in an acute fatal pneumonia model
A DiGiandomenico et al.
INFECTION AND IMMUNITY (2004)
Enhanced immunogenicity in the murine airway mucosa with an attenuated Salmonella live vaccine expressing OprF-OprI from Pseudomonas aeruginosa
H Arnold et al.
INFECTION AND IMMUNITY (2004)
Vaccination of cystic fibrosis patients against Pseudomonas aeruginosa reduces the proportion of patients infected and delays time to infection
AB Lang et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)
DNA vaccines against chronic lung infections by Pseudomonas aeruginosa
J Staczek et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2003)
Immunisation with non-integral OMPs promotes pulmonary clearance of Pseudomonas aeruginosa
LD Thomas et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2003)
Clinical study to assess the immunogenicity and safety of a recombinant Pseudomonas aeruginosa OprF-OprI vaccine in burn patients
E Mansouri et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2003)
Mucosal vaccination with a recombinant OprF-I vaccine of Pseudomonas aeruginosa in healthy volunteers:: comparison of a systemic vs. a mucosal booster schedule
K Göcke et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2003)
Construction and characterization of a Pseudomonas aeruginosa mucoid exopolysaccharide-alginate conjugate vaccine
C Theilacker et al.
INFECTION AND IMMUNITY (2003)
Protection against fatal Pseudomonas aeruginosa pneumonia in mice after nasal immunization with a live, attenuated aroA deletion mutant
GP Priebe et al.
INFECTION AND IMMUNITY (2003)
Construction and characterization of a live, attenuated aroA deletion mutant of Pseudomonas aeruginosa as a candidate intranasal vaccine
GP Priebe et al.
INFECTION AND IMMUNITY (2002)
Dual-function vaccine for Pseudomonas aeruginosa:: Characterization of chimeric exotoxin A-pilin protein
R Hertle et al.
INFECTION AND IMMUNITY (2001)
PcrV immunization enhances survival of burned Pseudomonas aeruginosa-infected mice
IA Holder et al.
INFECTION AND IMMUNITY (2001)
Structure of a pilin monomer from Pseudomonas aeruginosa -: Implications for the assembly of pili
DW Keizer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Protection against Pseudomonas aeruginosa chronic lung infection in mice by genetic immunization against outer membrane protein F (OprF) of P-aeruginosa
BM Price et al.
INFECTION AND IMMUNITY (2001)
Safety and immunogenicity of an intranasal Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers
M Larbig et al.
VACCINE (2001)
Role of alginate O acetylation in resistance of mucoid Pseudomonas aeruginosa to opsonic phagocytosis
GB Pier et al.
INFECTION AND IMMUNITY (2001)
Expression and testing of Pseudomanas aeruginosa vaccine candidate proteins prepared with the Caulobacter crescentus S-layer protein expression system
E Umelo-Njaka et al.
VACCINE (2001)
Comparison of two immunization schedules for a Pseudomonas aeruginosa outer membrane proteins vaccine in burn patients
DK Kim et al.
VACCINE (2000)
Mice immunized with DNA encoding a modified Pseudomonas aeruginosa exotoxin A develop protective immunity against exotoxin intoxication
JW Shiau et al.
VACCINE (2000)
Preparation and preclinical evaluation of a novel liposomal complete-core lipopolysaccharide vaccine
E Bennett-Guerrero et al.
INFECTION AND IMMUNITY (2000)
Immunogenic efficacy of differently produced recombinant vaccines candidates against Pseudomonas aeruginosa infections
BU von Specht et al.
JOURNAL OF BIOTECHNOLOGY (2000)
Catalase immunization from Pseudomonas aeruginosa enhances bacterial clearance in the rat lung
LD Thomas et al.
VACCINE (2000)
CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia
WC Tsai et al.
INFECTION AND IMMUNITY (2000)
Crystal structure of Pseudomonas aeruginosa PAK pilin suggests a main-chain-dominated mode of receptor binding
B Hazes et al.
JOURNAL OF MOLECULAR BIOLOGY (2000)
Immunization with a Pseudomonas aeruginosa elastase peptide reduces severity of experimental lung infections due to P-aeruginosa or Burkholderia cepacia
PA Sokol et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Immunization of burn-patients with a Pseudomonas aeruginosa outer membrane protein vaccine elicits antibodies with protective efficacy
NG Lee et al.
VACCINE (2000)
Immunization with a chimeric tobacco mosaic virus containing an epitope of outer membrane protein F of Pseudomonas aeruginosa provides protection against challenge with P-aeruginosa
J Staczek et al.
VACCINE (2000)
Analysis of immunization with DNA encoding Pseudomonas aeruginosa exotoxin A
KS Denis-Mize et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2000)
Share Paper
